TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.

Martin J van den Bent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.